Neuronetics_logo-RGB purple.png
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents
September 25, 2024 08:31 ET | Neuronetics
MALVERN, Pa., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
SeaStar_SM_LogoCard.png
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial
September 25, 2024 08:30 ET | SeaStar Medical Holding Corporation
DENVER, Sept. 25, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of...
RenovoCathPRImage
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
September 25, 2024 08:30 ET | RenovoRx, Inc.
LOS ALTOS, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies based on a...
Sonnet Logo Complete.png
Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split
September 25, 2024 08:30 ET | Sonnet BioTherapeutics Holdings, Inc.
PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted...
Byrna_Technologies_Logo.jpg
Byrna Technologies to Report Fiscal Third Quarter 2024 Financial Results on Wednesday, October 9, 2024 at 9:00 a.m. ET
September 25, 2024 08:30 ET | Byrna Technologies, Inc.
ANDOVER, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development,...
IBS Primary Logo Blue.png
UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety
September 25, 2024 08:30 ET | Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...
DSC-logo-md.jpg
Data Storage Corporation Secures Expanded Contract Servicing a Billion Dollar Insurance Company
September 25, 2024 08:30 ET | Data Storage Corp.
MELVILLE, N.Y., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of diverse business continuity solutions for disaster-recovery, cloud...
HeartCore-Logo-Source_final.jpg
HeartCore’s Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
September 25, 2024 08:30 ET | HeartCore Enterprises Inc.
NEW YORK and TOKYO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company...
enteralogo.png
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
September 25, 2024 08:30 ET | Entera Bio Ltd.; OPKO Health, Inc.
JERUSALEM and MIAMI, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (Entera), a leader in the development of orally delivered peptides, and OPKO Health, Inc. (NASDAQ: OPK) (OPKO)...
FinWiseBancorpOfficialLogo.png
FinWise Bancorp Announces Strategic Lending Program with PowerPay to Offer Transparent and Affordable Monthly Payments for Home Improvement and Elective Healthcare Purchases
September 25, 2024 08:15 ET | FinWise Bank
MURRAY, Utah, Sept. 25, 2024 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), parent company of FinWise Bank (the “Bank”), today announced the launch of a new...